💊 Medicine Name:
Etoposide
💠 Formulation:
Oral capsule
💪 Strength:
50 mg per capsule
📜 Description:
Etoposide is a semisynthetic derivative of podophyllotoxin, used as an antineoplastic agent. The 50 mg capsule form is designed for oral administration, offering an alternative to intravenous dosing in select cancer treatment protocols.
🌿 Nature:
- Cytotoxic agent, specifically a topoisomerase II inhibitor
- S-phase specific action with some effect in G2 phase
- Often used in combination regimens with other chemotherapeutics
- Oral bioavailability is variable; close monitoring is required
- Swallowed whole; do not crush or chew
🌟 Advantages:
- Oral form allows for ambulatory or home-based chemotherapy
- Reduces need for IV access in long-term regimens
- Suitable for maintenance, palliative, or convenient outpatient care
- Often used in diseases where high cumulative doses are needed
- Can be used interchangeably with IV in some protocols, under physician guidance
🎯 Indications / Uses:
- Small cell lung cancer (SCLC) – often in combination with cisplatin
- Testicular cancer – usually in BEP regimen (Bleomycin, Etoposide, Cisplatin)
- Lymphomas and leukemias – especially in relapsed/refractory cases
- Ovarian cancer, neuroblastoma, Ewing’s sarcoma
- Occasionally used in brain tumors and Kaposi’s sarcoma
📦 Packaging:
- Typically packed in HDPE or blister packs
- Each capsule contains 50 mg etoposide, in gelatin capsule form (often light brown/yellow)
- Available in bottles of 10, 20, or 100 capsules, depending on brand
- Requires handling precautions due to cytotoxic nature
🧊 Storage:
- Store at room temperature (15–25°C)
- Protect from light and moisture
- Keep out of reach of children
- Avoid exposure to heat or freezing temperatures
👨⚕️ Patient Advice:
- Take exactly as prescribed, with or without food
- Do not chew, break, or open capsules
- Swallow whole with a glass of water
- Handle with care – caregivers should wear gloves if touching the capsules
- Report symptoms like fever, bleeding, or mouth sores
- Use effective contraception during and after treatment
- Avoid live vaccines and contact with ill persons
- May require regular blood tests to monitor for bone marrow suppression